Antipsychotic Agents: all 1,683 studies that test it
Page 7 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic SubjectsCompletedNCT00312494Phase 3Results posted
- An Open-Label Trial of Aripiprazole in Autism Spectrum DisordersCompletedNCT00308074Phase 2Results posted
- Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)CompletedNCT00303602Phase 4Results posted
- ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and DeliriumTerminatedNCT00300391Phase 3Results posted
- Quetiapine Augmentation for Treatment-resistant PTSDCompletedNCT00292370Phase 4Results posted
- Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic ChangesTerminatedNCT00288353Phase 3Results posted
- A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.CompletedNCT00282464Phase 3Results posted
- Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)CompletedNCT00281320Phase 3Results posted
- Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)CompletedNCT00280566Phase 3Results posted
- Treatment of Children With ADHD Who do Not Fully Respond to StimulantsTerminatedNCT00279409Phase 2Results posted
- A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed EpisodeCompletedNCT00277212Phase 4Results posted
- PET Imaging and Olanzapine Treatment in Borderline Personality DisorderCompletedNCT00275301Not applicableResults posted
- Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I DisorderCompletedNCT00266630Phase 3Results posted
- Safety And Tolerability Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00265382Phase 3Results posted
- 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)CompletedNCT00265343Phase 3Results posted
- Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedNCT00265330Phase 3Results posted
- A Study of Aripiprazole (Abilify) in Patients With Bipolar ManiaCompletedNCT00261443Phase 4Results posted
- Olanzapine in the Treatment of Patients With Anorexia NervosaCompletedNCT00260962Phase 2Results posted
- Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With OlanzapineCompletedNCT00259272Phase 3Results posted
- Safety And Efficacy Of Ziprasidone In Adolescents With SchizophreniaTerminatedNCT00257192Phase 3Results posted
- Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)CompletedNCT00257166Phase 3Results posted
- Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaCompletedNCT00254202Phase 3Results posted
- Trial of Aripiprazole in the Treatment of CD in AdolescentsCompletedNCT00250705Phase 4Results posted
- Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT00241176Phase 4Results posted
- Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical TrialsCompletedNCT00239356Phase 3Results posted
- Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major DepressionCompletedNCT00237666Phase 4Results posted
- Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I DisorderCompletedNCT00227305Phase 3Results posted
- 12- Week Open Label Treatment of Refractory Bipolar DepressionCompletedNCT00223496Phase 4Results posted
- Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar DisordersCompletedNCT00221403Phase 3Results posted
- Abilify as an Adjunctive Treatment for Refractory DepressionCompletedNCT00220636Phase 4Results posted
- Geodon for the Treatment of Refractory Social Anxiety DisorderCompletedNCT00215150Phase 2Results posted
- The Effects of Aripiprazole on the Processing of Rewards in SchizophreniaTerminatedNCT00209027Not applicableResults posted
- A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderCompletedNCT00206102Phase 4Results posted
- Metabolic Effects of Antipsychotics in ChildrenCompletedNCT00205699Phase 4Results posted
- Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With AutismCompletedNCT00198107Phase 3Results posted
- Study of Aripiprazole (Abilify) in Children With Symptoms of ManiaCompletedNCT00194077Phase 3Results posted
- Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar DisorderCompletedNCT00194012Phase 3Results posted
- Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00190749Phase 4Results posted
- Seroquel in the Treatment of Dysphoric Hypomania in Bipolar IICompletedNCT00186043Phase 4Results posted
- Short Term Rescue Study of OlanzapineCompletedNCT00186017Phase 4Results posted
- Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia PatientsCompletedNCT00183625Phase 4Results posted
- Treatment of Mania Symptoms With Drug TherapyCompletedNCT00183443Phase 3Results posted
- Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar DisorderCompletedNCT00181883Phase 4Results posted
- Risperidone and Divalproex Sodium With MRI Assessment in Pediatric BipolarCompletedNCT00176202Phase 3Results posted
- Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031CompletedNCT00174447Phase 3Results posted
- 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)CompletedNCT00174265Phase 3Results posted
- 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)CompletedNCT00159783Phase 3Results posted
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of SchizophreniaCompletedNCT00158223Phase 4Results posted
- Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use DisorderCompletedNCT00156715Phase 4Results posted
- Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)CompletedNCT00156065Phase 3Results posted
- 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)CompletedNCT00145509Phase 3Results posted
- Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)CompletedNCT00145496Phase 3Results posted
- 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)CompletedNCT00145470Phase 3Results posted
- A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I DepressionCompletedNCT00141271Phase 3Results posted
- A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia NervosaCompletedNCT00140426Phase 4Results posted
- Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With SchizophreniaCompletedNCT00139737Phase 3Results posted
- A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood EpisodesCompletedNCT00132678Phase 3Results posted
- Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use DisorderCompletedNCT00130923Phase 4Results posted
- Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I DisorderCompletedNCT00129220Phase 3Results posted
- Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's DiseaseCompletedNCT00125138Phase 2Results posted
- Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety DisorderCompletedNCT00113295Phase 4Results posted
- Aripiprazole in Children and Adolescents With Bipolar I DisorderCompletedNCT00110461Phase 3Results posted
- A Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00105196Phase 3Results posted
- Aripiprazole Open-Label, Safety and Tolerability StudyCompletedNCT00102518Phase 3Results posted
- Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and AdolescentsCompletedNCT00102479Phase 1Results posted
- Aripiprazole in Adolescents With SchizophreniaCompletedNCT00102063Phase 3Results posted
- Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress DisorderCompletedNCT00099983Phase 2Results posted
- A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of SchizophreniaCompletedNCT00088634Phase 2Results posted
- A Study to Test the Safety and Tolerability of a New Medication in the Treatment of SchizophreniaCompletedNCT00088621Phase 2Results posted
- Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00088465Phase 3Results posted
- Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and AdolescentsCompletedNCT00057681Phase 3Results posted
- Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking ClozapineCompletedNCT00056498Phase 4Results posted
- Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)CompletedNCT00053703Phase 4Results posted
- Switching Medication to Treat SchizophreniaCompletedNCT00044655Phase 4Results posted
- A Comparison of Study Drug With Placebo and Haloperidol in Patients With SchizophreniaCompletedNCT00044044Phase 2Results posted
- Safety and Tolerability Study of Drug to Treat SchizophreniaCompletedNCT00044005Phase 2Results posted
- Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic DisordersCompletedNCT00001656Phase 4Results posted
- Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid TumorsActive, not recruitingNCT07841210Phase 2
- Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)CompletedNCT07691190Phase 1
- Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With SchizophreniaCompletedNCT07268430Not applicable
- Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency DepartmentCompletedNCT07246187Phase 3
- Treatment of Tinnitus With OlanzapineCompletedNCT07190482Phase 1
- Bioequivalence Assessment Between Two Cariprazine Hard Capsule FormulationsCompletedNCT07121868Phase 1
- Comparison of Haloperidol and Ondansetron in Reducing Postoperative Nausea and Vomiting in RA-SAB PatientsCompletedNCT07087925Not applicable
- Neurobiological Mechanisms of Pathological Rumination and Effects of AripiprazoleActive, not recruitingNCT06937476Not applicable
- A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective DisorderWithdrawnNCT06878833Phase 3
- Food Effect Study of VHX-896 in Healthy VolunteersCompletedNCT06803290Phase 1
- Food-effect Study of Ecopipam PharmacokineticsCompletedNCT06669091Phase 1
- A Study of Olanzapine After Intranasal and Intramuscular AdministrationCompletedNCT06600477Phase 1
- Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State ConditionsCompletedNCT06494397Phase 1
- Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain SicknessCompletedNCT06450899Phase 2
- Bioequivalence Study of Pimavanserin 34 mg CapsuleCompletedNCT06450184Phase 1
- Sequential Multiple Assignment Randomized Trial for Bipolar DepressionActive, not recruitingNCT06433635Phase 4
- Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONVCompletedNCT06428084Phase 2
- Detoxification From the Lipid TractCompletedNCT06357104Phase 4
- NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC RegimensCompletedNCT06331520Phase 3
- Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain SicknessCompletedNCT06310642Phase 4
- Effects of Antipsychotics on Brain Insulin Action in FemalesActive, not recruitingNCT06251635Not applicable
- Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With SchizophreniaCompletedNCT06236451Phase 4
- KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral SolutionCompletedNCT06218979Phase 1